Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes
- 23 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (4) , 1121-1137
Abstract
Diet therapy for inflammatory bowel disease (IBD) is an international research priority but guidance for IBD-specific diet trial design is lacking. This review critically evaluates key elements of prospective IBD food-based intervention trials and identifies gaps. Electronic databases were searched for interventional IBD diet studies. Prospective primary studies/trials were included if used food-based dietary strategies. Forty studies/trials evaluating 29 food-based strategies as therapy for IBD were identified. Considerable heterogeneity in diets, trial design, and methodology exists. Thirty-one trials (78%) intended the diet to modulate inflammation but 14/31 (46%) did not have a primary endpoint measuring an objective change in inflammatory activity and 20/31 (65%) controlled for medication stability prior to application of diet at baseline. Higher-quality IBD diet trials used symptom-based assessment tools coupled with an objective evaluation of inflammatory activity. Dietary advice trials are the most common. One-third of trials developed and administered diet education without a dietitian. Evaluation and reporting on adherence to diet therapy occurred in <60% of trials. Failure to include or report on key elements of trial design reduced the interpretability and validity of the results. This is a considerable limitation to advancing scientific knowledge in this area. Diet therapy trials should adhere to similar rigorous quality standards used to develop other IBD therapies. Therefore, a set of practical recommendations was generated to provide the authors’ perspective to help inform the future design of high-quality IBD diet trials.Keywords
This publication has 105 references indexed in Scilit:
- A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effectsJGH Open, 2023
- Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping reviewAppetite, 2021
- Ultra-processed Foods and Risk of Crohn’s Disease and Ulcerative Colitis: A Prospective Cohort StudyClinical Gastroenterology and Hepatology, 2021
- Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative ColitisClinical Gastroenterology and Hepatology, 2021
- Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn’s disease: results of a prospective cohort studyEuropean Journal of Pediatrics, 2019
- Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative ColitisClinical Gastroenterology and Hepatology, 2018
- The role of the microbiome for human health: from basic science to clinical applicationsEuropean Journal of Nutrition, 2018
- Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2018
- Treatment of Crohn’s Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled TrialDigestive Diseases and Sciences, 2016
- Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre Controlled TrialThe Lancet, 1993